🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Trading Operations

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.

After moments of joining one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious health risks”.